CLINICAL_TRIALS
trial_result
· 2011-10-17
Clinical Trial Update: A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
Phase 2 pilot study of OSI-461 in patients with chronic lymphocytic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED